dpp-4 inhibitors and glp-1 agonists Comparison of receptor GLP-1 receptor agonist versus DPP-4

This review also highlights the existing queries and evidence gaps in DPP-4 inhibitor research

Over the last few years, GLP-1 medications have been approved with indications strictly for weight loss and chronic weight management by the U.S

Regular follow-up during the first three months of treatment allows for timely intervention if side effects become problematic, maximizing the likelihood of successful long-term weight management while maintaining quality of life throughout the treatment journey

Obesity isnt just a therapeutic area, its a trillion-dollar gateway to treating diabetes, heart disease, and metabolic disorders

H.McguireJ

Stabilises blood sugar : They enhance insulin sensitivity and reduce blood sugar spikes